Location History:
- Westfield, NJ (US) (1993)
- Gladstone, NJ (US) (1993 - 1994)
- E. Greenwich, RI (US) (1996)
Company Filing History:
Years Active: 1993-1996
Title: Mary N Omstead: Innovator in Pharmaceutical Chemistry
Introduction
Mary N Omstead is a prominent inventor based in Gladstone, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. Her work primarily focuses on developing compounds that have therapeutic applications, particularly in cancer treatment and cholesterol management.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Inhibitors of farnesyl-protein transferase." This invention is directed to compounds that inhibit farnesyl-protein transferase (FPTase) and the farnesylation of the oncogene protein Ras. The invention also encompasses chemotherapeutic compositions containing these compounds and methods for inhibiting FPTase. Another notable patent is the "Process for forming cholesterol lowering compound using pseudodiplodia." This invention relates to a fungal microorganism, Pseudodiplodia sp. (MF5767), which is isolated from bark discs of Hibiscus sp. and is useful in a fermentation process to form compounds that act as squalene synthetase inhibitors, thereby serving as cholesterol-lowering agents.
Career Highlights
Mary N Omstead is currently associated with Merck & Company, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her research and inventions have the potential to impact the treatment of various diseases significantly.
Collaborations
She has collaborated with notable coworkers such as Gerald F Bills and Fernando Pelaez, further enhancing her research and development efforts.
Conclusion
Mary N Omstead is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in cancer treatment and cholesterol management. Her contributions are invaluable to the field and continue to inspire future innovations.